William Liesman, MD
Orthopaedic Surgery · Midland, TXNPI 1144665233
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (37.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Stryker at 39.0% of the total. Reporting peaked in 2019 at $6,960 and has fallen 63.6% since, to $2,536 in 2025.
Across 245 payments — averaging $91.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$9K
- Smith+Nephew$6K
- Arthrex$4K
- Rattan And Associates$3K
- Zimmer Biomet$669
- Amgen$165
- plus $497 from 11 others
What the payments were for
- Travel & lodging$5,93026%
- Food & beverage$8,17836%
- Education$8,41037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 165 | $8,771 |
| Smith+Nephew | 2 | $6,116 |
| Arthrex | 34 | $3,560 |
| Rattan And Associates | 12 | $2,738 |
| Zimmer Biomet | 6 | $669 |
| Amgen(2 entities) | 7 | $165 |
| Pacira Therapeutics, Inc. | 3 | $133 |
| Johnson & Johnson(2 entities) | 3 | $87 |
| Bioventus LLC | 2 | $77 |
| Heraeus Medical, LLC. | 1 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Vericel Corporation | 2 | $31 |
| Orthofix Medical, Inc. | 2 | $26 |
| FX Shoulder Solutions, Inc | 1 | $23 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,428
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,230
- PRO$751
- ACCOLADE$390
- TRIDENT$390
- TRIATHLON$289
- Connected Health-MyMobility$227
- Regeneten$189
- GAMMA$173
- TORNIER PERFORM REVERSED GLENOID$159
- LATITUDE EV$159
- T2 ALPHA$137
- ROSA$129
- ROSA-Knee$123
- AEQUALIS PERFORM REVERSED$115
- Zilretta$105
How this compares
$22,517 in reported general payments places this provider in the 80th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 235 | $2,812 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 278 | $2,231 |
| Gabapentin | 151 | $1,078 |
| Ondansetron OdtOndansetron | 120 | $897 |
| Methocarbamol | 42 | $520 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $146 |
| Cephalexin | 89 | $136 |
| Tramadol Hcl | 22 | $58 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $58 |
| Amoxicillin | 11 | $6 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Midland
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.